Asian Clinical Trial Management Systems (CTMS) Market Research Report

The Asian clinical trial management systems market, mainly driven by the increasing R&D investments in pharmaceutical, life sciences, and clinical research industries, along with integration of CTMS with HIS, and also the rising prevalence of diseases and increased clinical research outsourcing, was valued at $63.8 million in 2013 and is expected to reach $133.9 million by 2018, at a CAGR of 16% from 2013 to 2018.

The report analyzes the market in terms of 2 segments, such as enterprise CTMS and site CTMS.

Currently, the clinical trial outsourcing from Asian countries is increasing due to cost-effectiveness and large patient population availability in the region. Asia and the Rest of the World (RoW) contribute 7% and 3% respectively in the global market as the CTMS market has not entirely penetrated these regions. The Asian market is believed to offer good growth opportunities to CTMS, due to the increased clinical trial outsourcing trend from the western countries.

The industry segment holds the major share of 87% in the clinical trials market. 58% of the trials are handled by the industry, while 2% of the trials are handled by the industry segment in collaboration with healthcare providers, funded by grants. Nearly 14% of the trials are handled by industry in collaboration with healthcare providers, and all of these trials are self-financed trials without any grants.

Healthcare providers such as academic medical centers (AMCs), hospitals, cancer research centers, universities, and individual research centers also handle clinical trials that are outsourced by the pharmaceutical companies. The healthcare providers’ segment holds 19% of the total clinical trials, where all these trials are sponsored by the pharmaceutical industry and have been outsourced to the healthcare providers’ segment. These statistics indicate that the percentage of clinical trials that are outsourced to healthcare providers are very less compared to CROs, wherein financial dependency of healthcare providers on the funds and grants received from NIH, the U.S. Federal Agency, and other organizations and state governments, is considered as the major restraint of the healthcare providers’ market, limiting the number of clinical trials outsourced to healthcare providers.

The report also provides an extensive competitive landscaping of the leading companies operating in this market. The main companies that are extensively covered in this report include Oracle Corporation, Perceptive Informatics (PAREXEL), Medidata Solutions, eResearch Technology Solutions, Bioclinica, Datatrak international, Inc., and Pharmaceutical Product Development, Llc. Furthermore, segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.

Customization Options:

Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and deep dive analysis of the following parameters:

Product Analysis

• Usage pattern (in-depth trend analysis) of products (segment-wise)
• Product matrix, which gives a detailed comparison of product portfolio of each company, mapped at country and sub-segment levels
• End-user adoption rate analysis of the products (segment-wise and country-wise)
• Comprehensive coverage of product approvals, pipeline products, and product recalls

Pharmacists’ Forum

• Fast turn-around analysis of pharmacists’ responses to market events and trends
• Pharmacists’ opinions about products from different companies
• Pharmacists’ qualitative inputs on epidemiology data
• Pattern analysis of usage of drugs by physicians

Brand/Product Perception Matrix

• A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
• An analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)

Please fill in the form below to receive a free copy of the Summary of this Report

* First Name :

* Last Name :

* Designation :

* Company :

* Email(Username) :

* Phone :

* Country :

-- Select Country -- India Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antigua Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia Herzegovina Botswana Brazil British Virgin Island Brunei Darussalam Bulgaria Burkina Faso Burundi Cote d'Ivoire Cambodia Cameroon Canada Cape Verde Cayman Isls Central African Republic Chad Chile China Colombia Comoros Congo Cook Island Costa Rica Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Faroe Islands Falkland Islands (Malvinas) Fiji Finl France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenl Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Holy See Honduras Hong Kong Special Administrative Hungary Iceland Indonesia Iran (Islamic Republic of Iran) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Special Administrative Region of China Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Micronesia Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherland Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Islands Northern Mariana Islands Norway Occupied Palestinian Territory Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Republic of Korea Republic of Moldova Romania Russian Federation Rwa Saint Helena Saint Kitts Nevis Saint Lucia Saint Pierre Miquelon Saint Vincent the Grenadines Samoa San Marino Sao Tome Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Svalbard Jan Mayen Islands Swazil Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tokelau Tonga Trinidad Tobago Tunisia Turkey Turkmenistan Turks Caicos Isls Tuvalu Uga Ukraine United Arab Emirates United Kingdom United Republic of Tanzania United States United States Virgin Isls Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Wallis Futuna Isls Western Sahara Yemen Yugoslavia Zambia Zimbabwe

Comments :

Reports Interested in :Asian Clinical Trial Management Systems (CTMS) Market Research Report

* Enter the text from the image to the text box :